Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 2,373 shares at $12.01 ($28K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $28k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |
| ADPT | SELL | 2020-11-10 | $592K | — | Filing → |